Alyeska Investment Group’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Alyeska Investment Group's VCYT Position: Q2 2026 in Review
Alyeska Investment Group reduced its Veracyte (VCYT) stake by 36% in Q2 2026, selling an estimated $12.2M and leaving 518,043 shares worth $30.4M. The position accounts for 0.08% of the portfolio, ranked #279.
Alyeska Investment Group first reported a position in VCYT in Q4 2013 and has held it in 11 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Alyeska Investment Group held 518,043 shares of Veracyte worth $30.4M as of Q2 2026.
- Alyeska Investment Group sold 290,527 Veracyte shares in Q2 2026, an estimated $12.2M.
- Veracyte made up 0.08% of Alyeska Investment Group's portfolio in Q2 2026, its #279 holding.
- Alyeska Investment Group first reported a position in Veracyte in Q4 2013 and has held it in 11 quarters since.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.